FAQs BPC-157 (Body Protection Compound-157) is a synthetic peptide widely used in research for its potential to accelerate healing of musculoskeletal injuries, including tendons, ligaments, muscles, and bones
Even absent these logistical hurdles, pharmaceutical companies might not want to invest in clinical trials
Phase 3 starts Q1 2026 Phase 3 GLP-1/Amylin VK2735 Viking Therapeutics Dual GLP-1/GIP agonist
Everyone at Clinic 45 is always so nice and knowledgeable!" Catherine E
This encourages safe, gradual titration without financial penalties, helping you find your optimal dose while minimizing side effects like fatigue
Clinical studies of certain FDA-approved weight management medications have shown meaningful weight loss for many patients when medication is combined with a reduced-calorie diet and increased physical activity